Concerning the head and neck region, the expression of SOX2 was found much higher in laryngeal carcinoma tissues, and high SOX2 expression is associated with late clinical stage and early recurrence in laryngeal carcinoma. This evidence concerns the gene SOX2 and laryngeal carcinoma.